Replies to post #90749 on Biotech Values

[DewDiligence]

ITMN VRUS Roche etc:

I'm starting to see a negative trend in development. The fact that 7227 needs ritonavir boosting should raise a red flag.

I fully agree—please see my reply to ghmm in #msg-46797334.